Calix Ltd (CXL)

Top insiders
Trades
Dr. Mark Geoffrey Sceats
1 purchase — total 439,000 AUD
Buy 24 Aug 2023
Value A$1,895,564.19 | Price 185.23 | Shares 48,399
Planned buy 17 Nov 2022
Value A$792,273.67 | Price 41.68 | Shares 13,495
Planned buy 17 Nov 2022
Value A$15,001.12 | Price 4.24 | Shares 3,538
Planned buy 17 Nov 2022
Value A$15,001.12 | Price 4.24 | Shares 3,538
Planned buy 17 Nov 2022
Value A$90,006.72 | Price 4.24 | Shares 21,228
Planned buy 17 Nov 2022
Value A$30,002.24 | Price 4.24 | Shares 7,076
Sale 24 Oct 2022
Value A$1,500,003.05 | Price 4.55 | Shares 329,671
Sale 24 Oct 2022
Value A$880,001.85 | Price 4.55 | Shares 193,407
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-08-29 2023-08-24 B Purchase Dr. Mark Geoffrey Sceats Director
48,399
185.23
A$1,895,564
48,399 185.23 A$1,895,564
2022-11-23 2022-11-17 PP Planned purchase Peter John Turnbull Director
13,495
41.68
A$792,274
13,495 41.68 A$792,274
2022-11-23 2022-11-17 PP Planned purchase Dr. Mark Geoffrey Sceats Director
21,173
324.23
A$2,663,664
21,173 324.23 A$2,663,664
2022-11-23 2022-11-17 PP Planned purchase Dr. Philip Hargraves Hodgson Director
3,538
4.24
A$15,001
3,538 4.24 A$15,001
2022-11-23 2022-11-17 PP Planned purchase Dr. John Andrew Hamilton Director
21,228
4.24
A$90,007
21,228 4.24 A$90,007
2022-11-23 2022-11-17 PP Planned purchase Helen Fisher Director
7,076
4.24
A$30,002
7,076 4.24 A$30,002
2022-10-25 2022-10-24 S Sale Dr. Mark Geoffrey Sceats Director
329,671
4.55
A$1,500,003
329,671 4.55 A$1,500,003
2022-10-25 2022-10-24 S Sale Dr. Philip Hargraves Hodgson Director
193,407
4.55
A$880,002
193,407 4.55 A$880,002